Endothelial estrogen receptor isoforms and cardiovascular disease

Area of Science:

• Cardiovascular Biology
• Endocrinology
• Molecular Biology

Background:

• Estrogen exerts rapid, nongenomic effects on vascular cells, distinct from classical genomic actions.
• Evidence supports beneficial roles of ovarian steroid hormones in the vasculature.
• Endothelial plasma membrane-associated estrogen receptor alpha (ERα) mediates rapid signaling, including nitric oxide (NO) release.

Purpose of the Study:

• To review estrogen receptor (ER) isoforms involved in rapid endothelial signaling.
• To discuss the role of ERα66 and ERα46 in 17β-estradiol (E2)-stimulated endothelial responses.
• To highlight the significance of ER46's transmembrane orientation and its clinical implications.

Main Methods:

• Review of existing clinical and pre-clinical data.
• Discussion of molecular mechanisms of ER signaling in endothelial cells.
• Analysis of ER isoform structure and function.

Main Results:

• Nongenomic vascular responses to estrogen are well-established.
• ERα, particularly the ERα46 isoform, is crucial for rapid endothelial signaling.
• ER46 functions as a Type I integral transmembrane molecule in these responses.

Conclusions:

• Rapid endothelial signaling pathways involving ER isoforms are critical for vascular health.
• The specific transmembrane orientation of ER46 influences its signaling capacity.
• Understanding these nongenomic effects provides clinical insights into hormone-mediated cardiovascular protection.